ANSES Reiterates Recommendation to Restrict Use of Products Containing Nanomaterials “That Are of Little Benefit to the Population”

Bergeson & Campbell, P.C.
Contact

Bergeson & Campbell, P.C.

On June 3, 2021, the French Agency for Food, Environmental and Occupational Health and Safety (ANSES) published an interview with Aurélie Niaudet, who is in charge of assessing the risks associated with physical agents. Niaudet states that nanomaterials have novel properties that “are highly sought after and increasingly exploited, but can also induce specific types of behaviour when interacting with humans or the environment.” After the human body is exposed, “there is then the question of the distribution and possible accumulation of these nanomaterials in the various organs.” According to Niaudet, “assessing the risks associated with nanomaterials involves three steps: agreeing on criteria for defining them, describing the main types of exposure, and understanding their behaviour and effects.” As reported in our previous blog items, ANSES’s work on nanomaterials has addressed titanium dioxide and nano silver, and recently included a review of the presence of engineered nanomaterials in food. ANSES also manages the R-Nano register and published an analysis in 2020 that “highlighted the poor quality of the reported data and led ANSES to issue recommendations to declaring companies and to the ministries to consolidate this register and increase its usefulness.” ANSES also coordinates the National Research Program for Environmental and Occupational Health, funding research on the effects and environmental fate of nanomaterials, as well as on monitoring population exposure.

To protect people, Niaudet recommends that, in addition to strengthening the regulatory framework, “it is also important to limit exposure of the population and the environment as a precautionary measure, by choosing safe products that are equally effective but free of nanomaterials.” Niaudet states that ANSES “reiterates its recommendation to restrict the use of products containing nanomaterials that are of little benefit to the population.”

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bergeson & Campbell, P.C. | Attorney Advertising

Written by:

Bergeson & Campbell, P.C.
Contact
more
less

Bergeson & Campbell, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.